Tenet Healthcare (THC) PT Raised to $30 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts THC Hot Sheet
Price: $268.89 -1.6%
Rating Summary:
24 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Rating Summary:
24 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Join SI Premium – FREE
RBC Capital analyst Frank Morgan raised the price target on Tenet Healthcare (NYSE: THC) to $30.00 (from $26.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Tenet Healthcare (THC) PT Raised to $305 at Mizuho
- Tenet Healthcare (THC) PT Raised to $304 at RBC Capital
- Estee Lauder (EL) PT Raised to $129 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
